One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

Zydus Lifesciences has partnered with Synthon BV in a deal to develop, license, supply, and commercialize a novel oncology ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...

Having raised more than $1 million toward cancer research over the past nine years, the tournament is on the road to raising ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

A.I. in Action A.I. algorithms played a crucial role in the rapid development of mRNA vaccines during the COVID-19 pandemic. They have also helped get potentially life-saving cancer drugs into ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...